Earlier this month, London got a new member of its FTSE100 index, as GlaxoSmithKline split, amoeba-like, its non-drugs business from the pharmaceuticals.
GlaxoSmithKline split: a parable for Britain today
GlaxoSmithKline split: a parable for Britain…
GlaxoSmithKline split: a parable for Britain today
Earlier this month, London got a new member of its FTSE100 index, as GlaxoSmithKline split, amoeba-like, its non-drugs business from the pharmaceuticals.